Cargando…
Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing’s
Introduction: Ewing’s sarcoma (ES) is the second most common bone tumor in children. Survival has not improved over the last decade and once pulmonary metastatic disease is present, survival is dismal. Mesenchymal stromal cell (MSC) therapy has shown potential benefit for Kaposi’s sarcoma; however,...
Autores principales: | Hayes-Jordan, Andrea, Wang, Yong Xin, Walker, Peter, Cox, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039072/ https://www.ncbi.nlm.nih.gov/pubmed/24910847 http://dx.doi.org/10.3389/fped.2014.00044 |
Ejemplares similares
-
Primary renal Ewing Sarcoma masquerading as Wilms in an adolescent female
por: Kozel, Zachary M., et al.
Publicado: (2020) -
The Potential of Mesenchymal Stromal Cell as Therapy in Neonatal Diseases
por: Liau, Ling Ling, et al.
Publicado: (2020) -
Case Report: Primary Ewing Sarcoma of the Penis With Multiple Metastases
por: Zheng, Chuanxi, et al.
Publicado: (2021) -
Targeting Glutathione S-transferase M4 in Ewing sarcoma
por: Zhuo, Rupeng, et al.
Publicado: (2014) -
Effects of Socioeconomic and Geographic Factors on Outcomes in Ewing Sarcoma: A National Cancer Database Review
por: McMahon, Kevin M, et al.
Publicado: (2022)